FDA approves remdesivir as first treatment for coronavirus
Thursday, 22 October 2020 The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes in COVID-19 cases. Janet Shamlian reports.
On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%